Camille Bachelet, PhD
@camillebachelet.bsky.social
Passionate about cell therapy, I explore innovative technologies to advance the field. Curious and always learning, I enjoy exchanging ideas on biotechnology and regenerative medicine.
🧬 A recent Nature Medicine study shows promising results in phase 1 with BNT221, a personalized autologous T cell therapy:
✅ Well tolerated with no dose-limiting toxicities
✅ Stable disease in 6/9 patients
✅ Tumor reductions up to 20%
#clinicaltrial #CART #cellandgenetherapy
✅ Well tolerated with no dose-limiting toxicities
✅ Stable disease in 6/9 patients
✅ Tumor reductions up to 20%
#clinicaltrial #CART #cellandgenetherapy
February 4, 2025 at 1:00 PM
🧬 A recent Nature Medicine study shows promising results in phase 1 with BNT221, a personalized autologous T cell therapy:
✅ Well tolerated with no dose-limiting toxicities
✅ Stable disease in 6/9 patients
✅ Tumor reductions up to 20%
#clinicaltrial #CART #cellandgenetherapy
✅ Well tolerated with no dose-limiting toxicities
✅ Stable disease in 6/9 patients
✅ Tumor reductions up to 20%
#clinicaltrial #CART #cellandgenetherapy
Excited to join the Bluesky community ! As someone passionate about advancing #ATMPs, I’m here to share insights and engage in conversations around #biotechnology, #regenerativemedicine, and the future of healthcare. 🚀
We’re at the forefront of groundbreaking technologies that are changing lives !
We’re at the forefront of groundbreaking technologies that are changing lives !
February 4, 2025 at 12:50 PM
Excited to join the Bluesky community ! As someone passionate about advancing #ATMPs, I’m here to share insights and engage in conversations around #biotechnology, #regenerativemedicine, and the future of healthcare. 🚀
We’re at the forefront of groundbreaking technologies that are changing lives !
We’re at the forefront of groundbreaking technologies that are changing lives !